Environmental causes: Viral causes

Endocrinology and Metabolism Clinics of North America

Volumn 33, Issue 1, 2004, Pages 27-44

  Hyöty, Heikki ^a,b  

^a Juvenile Diabetes Research Foundation International   (United States)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR3 ANTIGEN; HLA DR4 ANTIGEN;

B LYMPHOCYTE; CHRONIC DISEASE; CLINICAL FEATURE; CLINICAL RESEARCH; CONGENITAL RUBELLA SYNDROME; COXSACKIE VIRUS B; CROSS REACTION; CYTOMEGALOVIRUS; DIABETOGENESIS; DISEASE ASSOCIATION; ENTEROVIRUS; ENVIRONMENTAL FACTOR; FETUS DEVELOPMENT; FIRST TRIMESTER PREGNANCY; FOLLOW UP; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; ONTOGENY; PANCREAS ISLET CELL; PARVOVIRUS; PICORNAVIRUS; PRIORITY JOURNAL; RETROVIRUS; REVIEW; RISK FACTOR; RUBELLA VIRUS; SEROTYPE; T LYMPHOCYTE; VIRUS ETIOLOGY; VIRUS STRAIN;

ANIMALIA; COXSACKIEVIRUS; CYTOMEGALOVIRUS; ENTEROVIRUS; HUMAN ENTEROVIRUS B; PARVOVIRUS; PICORNAVIRIDAE; RUBELLA VIRUS; UNIDENTIFIED RETROVIRUS;

EID: 17444453128     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2003.12.004     Document Type: Review

References (117)

1. Szopa T.M., Titchener P.A., Portwood N.D., Taylor K.W. Diabetes mellitus due to viruses-some recent developments. Diabetologia. 36:(8):1993;687-695.
2. Hyöty H., Taylor K. The role of viruses in human diabetes. Diabetologia. 45:2002;1353-1361.
3. Makela S., Mustonen J., Ala-Houhala I., Hurme M., Partanen J., Vapalahti O., et al. Human leukocyte antigen-B8-DR3 is a more important risk factor for severe Puumala hantavirus infection than the tumor necrosis factor-alpha(-308) G/A polymorphism. J Infect Dis. 186:(6):2002;843-846.
4. Hogan C.M., Hammer S.M. Host determinants in HIV infection and disease Part 2: genetic factors and implications for antiretroviral therapeutics. Ann Intern Med. 134:(10):2001;978-996.
5. Kaslow R.A., Rivers C., Tang J., Bender T.J., Goepfert P.A., El Habib R., et al. Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines. J Virol. 75:(18):2001;8681-8689.
6. Barrett S., Goh J., Coughlan B., Ryan E., Stewart S., Cockram A., et al. The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection. Gut. 49:(3):2001;423-430.
7. Grimes D.A., Schulz K.F. Bias and causal associations in observational research. Lancet. 359:(9302):2002;248-252.
8. Kaufman J.S., Poole C. Looking back on "causal thinking in the health sciences." Annu Rev Public Health. 21:2000;101-119.
9. Weed D.L. Interpreting epidemiological evidence: how meta-analysis and causal inference methods are related. Int J Epidemiol. 29:(3):2000;387-390.
10. Jun H.S., Yoon J.W. A new look at viruses in type 1 diabetes. Diabetes Metab Res Rev. 19:(1):2003;8-31.
11. Jaeckel E., Manns M., Von Herrath M. Viruses and diabetes. Ann N Y Acad Sci. 958:2002;7-25.
12. Viskari H., Paronen J., Keskinen P., Simell S., Zawilinska B., Zgorniak-Nowosielska I., et al. Humoral beta-cell autoimmunity is rare in patients with the congenital rubella syndrome. Clin Exp Immunol. 133:(3):2003;378-383.
13. Menser M.A., Dods L., Harley J.D. A twenty-five-year follow-up of congenital rubella. Lancet. 2:(7530):1967;1347-1350.
14. Ginsberg-Fellner F., Witt M.E., Fedun B., Taub F., Dobersen M.J., McEvoy R.C., et al. Diabetes mellitus and autoimmunity in patients with the congenital rubella syndrome. Rev Infect Dis. 7:(Suppl 1):1985;S170-S176.
15. McEvoy R.C., Fedun B., Cooper L.Z., Thomas N.M., Rudriguez de Cordoba S., Rubinstein P., et al. Children at high risk of diabetes mellitus: New York studies of families with diabetes and of children with congenital rubella syndrome. Adv Exp Med Biol. 246:1988;221-227.
16. Clarke W.L., Shaver K.A., Bright G.M., Rogol A.D., Nance W.E. Autoimmunity in congenital rubella syndrome. J Pediatr. 104:(3):1984;370-373.
17. Rabinowe S.L., George K.L., Loughlin R., Soeldner J.S., Eisenbarth G.S. Congenital rubella. Monoclonal antibody-defined T cell abnormalities in young adults. Am J Med. 81:(5):1986;779-782.
18. Ou D., Mitchell L.A., Metzger D.L., Gillam S., Tingle A.J. Cross-reactive rubella virus and glutamic acid decarboxylase (65 and 67) protein determinants recognised by T cells of patients with type I diabetes mellitus. Diabetologia. 43:(6):2000;750-762.
19. Numazaki K., Goldman H., Wong I., Wainberg M.A. Infection of cultured human fetal pancreatic islet cells by rubella virus. Am J Clin Pathol. 91:(4):1989;446-451.
20. Numazaki K., Goldman H., Seemayer T.A., Wong I., Wainberg M.A. Infection by human cytomegalovirus and rubella virus of cultured human fetal islets of Langerhans. In Vivo. 4:(1):1990;49-54.
21. Rayfield E.J., Kelly K.J., Yoon J.W. Rubella virus-induced diabetes in the hamster. Diabetes. 35:(11):1986;1278-1281.
22. Menser M.A., Forrest J.M., Bransby R.D. Rubella infection and diabetes mellitus. Lancet. 1:(8055):1978;57-60.
23. Rubinstein P., Walker M.E., Fedun B., Witt M.E., Cooper L.Z., Ginsberg-Fellner F. The HLA system in congenital rubella patients with and without diabetes. Diabetes. 31:(12):1982;1088-1091.
24. Gamble D.R., Taylor K.W. Seasonal incidence of diabetes mellitus. BMJ. 3:(671):1969;631-633.
25. Gamble D.R., Kinsley M.L., FitzGerald M.G., Bolton R., Taylor K.W. Viral antibodies in diabetes mellitus. BMJ. 3:(671):1969;627-630.
26. Green A., Patterson C.C. Trends in the incidence of childhood-onset diabetes in Europe 1989-1998. Diabetologia. 44:(Suppl 3):2001;B3-B8.
27. Kimpimaki T., Kupila A., Hamalainen A.M., Kukko M., Kulmala P., Sarola K., et al. The first signs of beta-cell autoimmunity appear in infancy in genetically susceptible children from the general population: the Finnish Type 1 Diabetes Prediction and Prevention Study. J Clin Endoctinol Metab. 86:(10):2001;4782-4788.
28. Hyöty H. Enterovirus infections and type 1 diabetes. Ann Med. 34:(3):2002;138-147.
29. Smith C.P., Clements G.B., Riding M.H., Collins P., Bottazzo G.F., Taylor K.W. Simultaneous onset of type 1 diabetes mellitus in identical infant twins with enterovirus infection. Diabet Med. 15:(6):1998;515-517.
30. Chehadeh W., Weill J., Vantyghem M.C., Alm G., Lefebvre J., Wattre P., et al. Increased level of interferon-alpha in blood of patients with insulin-dependent diabetes mellitus: relationship with coxsackievirus B infection. J Infect Dis. 181:(6):2000;1929-1939.
31. Frisk G., Nilsson E., Tuvemo T., Friman G., Diderholm H. The possible role of Coxsackie A and echoviruses in the pathogenesis of type I diabetes mellitus studied by IgM analysis. J Infect. 24:(1):1992;13-22.
32. Otonkoski T., Roivainen M., Vaarala O., Dinesen B., Leipala J.A., Hovi T., et al. Neonatal Type I diabetes associated with maternal echovirus 6 infection: a case report. Diabetologia. 43:(10):2000;1235-1238.
33. Vreugdenhil G.R., Schloot N.C., Hoorens A., Rongen C., Pipeleers D.G., Melchers W.J., et al. Acute onset of type I diabetes mellitus after severe echovirus 9 infection: putative pathogenic pathways. Clin Infect Dis. 31:(4):2000;1025-1031.
34. Diaz-Horta O., Bello M., Cabrera-Rode E., Suarez J., Mas P., Garcia I., et al. Echovirus 4 and type 1 diabetes mellitus. Autoimmunity. 34:(4):2001;275-281.
35. Cabrera-Rode E., Sarmiento L., Tiberti C., Molina G., Barrios J., Hernandez D., et al. Type 1 diabetes islet associated antibodies in subjects infected by echovirus 16. Diabetologia. 46:(10):2003;1348-1353.
36. Dotta F., Marselli L., Dionisi S., Scipioni A., Masieni A., vanHalteren A., et al. Demonstration of enterovirus infection in islets of two patients with type 1 diabetes. Diab Metab Res Rev. 18:2002;s16.
37. Yoon J.W., Austin M., Onodera T., Notkins A.L. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med. 300:(21):1979;1173-1179.
38. Sussman M.L., Strauss L., Hodes U.L. Fatal coxsackie B virus infections in the newborn. Report of case with necropsy findings and brief review of the literature. Am J Dis Child. 97:1959;483-492.
39. Jenson A.B., Rosenberg H.S., Notkins A.L. Pancreatic islet-cell damage in children with fatal viral infections. Lancet. 1:1980;354-358.
40. Ujevich M.M. Jr. Pancreatic islet cell damage. Its occurrence in neonatal coxsackievirus encephalomyocarditis. Arch Pathol Lab Med. 104:1980;438-441.
41. Ahmad N., Abraham A.A. Pancreatic isleitis with coxsackievirus B5 infection. Hum Pathol. 13:1982;661-662.
42. Foulis A.K., McGill M., Farquharson M.A., Hilton D.A. A search for evidence of viral infection in pancreases of newly diagnosed patients with IDDM. Diabetologia. 40:(1):1997;53-61.
43. Varela-Calvino R., Ellis R., Sgarbi G., Dayan C.M., Peakman M. Characterization of the T-cell response to coxsackievirus B4: evidence that effector memory cells predominate in patients with type 1 diabetes. Diabetes. 51:(6):2002;1745-1753.
44. Juhela S., Hyoty H., Roivainen M., Harkonen T., Putto-Laurila A., Simell O., et al. T-cell responses to enterovirus antigens in children with type 1 diabetes. Diabetes. 49:(8):2000;1308-1313.
45. Jones D.B., Crosby I. Proliferative lymphocyte responses to virus antigens homologous to GAD65 in IDDM. Diabetologia. 39:(11):1996;1318-1324.
46. Juhela S., Hyoty H., Hinkkanen A., Elliott J., Roivainen M., Kulmala P., et al. T cell responses to enterovirus antigens and to beta-cell autoantigens in unaffected children positive for IDDM-associated autoantibodies. J Autoimmun. 12:(4):1999;269-278.
47. Palmer J.P., Cooney M.K., Ward R.H., Hansen J.A., Brodsky J.B., Ray C.G., et al. Reduced Coxsackie antibody titres in type 1 (insulin-dependent) diabetic patients presenting during an outbreak of Coxsackie B3 and B4 infection. Diabetologia. 22:(6):1982;426-429.
48. Viskari H.R., Roivainen M., Reunanen A., Pitkaniemi J., Sadeharju K., Koskela P., et al. Maternal first-trimester enterovirus infection and future risk of type 1 diabetes in the exposed fetus. Diabetes. 51:(8):2002;2568-2571.
49. See D.M., Tilles J.G. Pathogenesis of virus-induced diabetes in mice. J Infect Dis. 171:(5):1995;1131-1138.
50. Berger M.M., See D.M., Aymard M., Lina B. Demonstration of persistent enterovirus in the pancreas of diabetic mice by in situ polymerase chain reaction. Clin Diagn Virol. 9:(2-3):1998;141-143.
51. Foulis A.K., Farquharson M.A., Meager A. Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus. Lancet. 2:(8573):1987;1423-1427.
52. Foulis A.K., Farquharson M.A., Cameron S.O., McGill M., Schonke H., Kandolf R. A search for the presence of the enteroviral capsid protein VP1 in pancreases of patients with type 1 (insulin-dependent) diabetes and pancreases and hearts of infants who died of coxsackieviral myocarditis. Diabetologia. 33:(5):1990;290-298.
53. Buesa-Gomez J., de la Torre J.C., Dyrberg T., Landin-Olsson M., Mauseth R.S., Lernmark A., et al. Failure to detect genomic viral sequences in pancreatic tissues from two children with acute-onset diabetes mellitus. J Med Virol. 42:(2):1994;193-197.
54. Parkkonen P., Hyöty H., Koskinen L., Leinikki P. Mumps virus infects beta cells in human fetal islet cell cultures upregulating the expression of HLA class I molecules. Diabetologia. 35:(1):1992;63-69.
55. Frisk G., Diderholm H. Tissue culture of isolated human pancreatic islets infected with different strains of coxsackievirus B4: assessment of virus replication and effects on islet morphology and insulin release. Int J Exp Diabetes Res. 1:(3):2000;165-175.
56. Roivainen M., Rasilainen S., Ylipaasto P., Nissinen R., Ustinov J., Bouwens L., et al. Mechanisms of coxsackievirus-induced damage to human pancreatic beta-cells. J Clin Endocrinol Metab. 85:(1):2000;432-440.
57. Bruserud O., Jervell J., Thorsby E. HLA-DR3 and -DR4 control T-lymphocyte responses to mumps and Coxsackie B4 virus: studies on patients with type 1 (insulin-dependent) diabetes and healthy subjects. Diabetologia. 28:(7):1985;420-426.
58. Sadeharju K., Knip M., Hiltunen M., Akerblom H.K., Hyöty H. The HLA-DR phenotype modulates the humoral immune response to enterovirus antigens. Diabetologia. 46:(8):2003;1100-1105.
59. Kaufman D.L., Erlander M.G., Clare-Salzler M., Atkinson M.A., Maclaren N.K., Tobin A.J. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest. 89:(1):1992;283-292.
60. Atkinson M.A., Bowman M.A., Campbell L., Darrow B.L., Kaufman D.L., Maclaren N.K. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J Clin Invest. 94:(5):1994;2125-2129.
61. Marttila J., Juhela S., Vaarala O., Hyöty H., Roivainen M., Hinkkanen A., et al. Responses of coxsackievirus B4-specific T-cell lines to 2C protein-characterization of epitopes with special reference to the GAD65 homology region. Virology. 284:(1):2001;131-141.
62. Schloot N.C., Willemen S.J., Duinkerken G., Drijfhout J.W., de Vries R.R., Roep B.O. Molecular mimicry in type 1 diabetes mellitus revisited: T-cell clones to GAD65 peptides with sequence homology to Coxsackie or proinsulin peptides do not crossreact with homologous counterpart. Hum Immunol. 62:(4):2001;299-309.
63. Lonnrot M., Hyöty H., Knip M., Roivainen M., Kulmala P., Leinikki P., et al. Antibody cross-reactivity induced by the homologous regions in glutamic acid decarboxylase (GAD65) and 2C protein of coxsackievirus B4. Childhood Diabetes in Finland Study Group. Clin Exp Immunol. 104:(3):1996;398-405.
64. Harkonen T., Lankinen H., Davydova B., Hovi T., Roivainen M. Enterovirus infection can induce immune responses that cross-react with beta-cell autoantigen tyrosine phosphatase IA-2/IAR. J Med Virol. 66:(3):2002;340-350.
65. Harkonen T., Puolakkainen M., Sarvas M., Airaksinen U., Hovi T., Roivainen M. Picornavirus proteins share antigenic determinants with heat shock proteins 60/65. J Med Virol. 62:(3):2000;383-391.
66. Harkonen T., Paananen A., Lankinen H., Hovi T., Vaarala O., Roivainen M. Enterovirus infection may induce humoral immune response reacting with islet cell autoantigens in humans. J Med Virol. 69:(3):2003;426-440.
67. Horwitz M.S., Fine C., Ilic A., Sarvetnick N. Requirements for viral-mediated autoimmune diabetes: beta-cell damage and immune infiltration. J Autoimmun. 16:(3):2001;211-217.
68. Serreze D.V., Ottendorfer E.W., Ellis T.M., Gauntt C.J., Atkinson M.A. Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes. 49:(5):2000;708-711.
69. Horwitz M.S., Bradley L.M., Harbertson J., Krahl T., Lee J., Sarvetnick N. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med. 4:(7):1998;781-785.
70. Yin H., Berg A.K., Westman J., Hellerstrom C., Frisk G. Complete nucleotide sequence of a Coxsackievirus B-4 strain capable of establishing persistent infection in human pancreatic islet cells: effects on insulin release, proinsulin synthesis, and cell morphology. J Med Virol. 68:(4):2002;544-557.
71. Chehadeh W., Kerr-Conte J., Pattou F., Alm G., Lefebvre J., Wattre P., et al. Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells. J Virol. 74:(21):2000;10153-10164.
72. Vaarala O., Klemetti P., Juhela S., Simell O., Hyöty H., Ilonen J. Effect of coincident enterovirus infection and cows' milk exposure on immunisation to insulin in early infancy. Diabetologia. 45:(4):2002;531-534.
73. Honeyman M.C., Coulson B.S., Stone N.L., Gellert S.A., Goldwater P.N., Steele C.E., et al. Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes. Diabetes. 49:(8):2000;1319-1324.
74. Blomqvist M., Juhela S., Erkkila S., Korhonen S., Simell T., Kupila A., et al. Rotavirus infections and development of diabetes-associated autoantibodies during the first 2 years of life. Clin Exp Immunol. 128:(3):2002;511-515.
75. Honeyman M.C., Stone N.L., Harrison L.C. T-cell epitopes in type 1 diabetes autoantigen tyrosine phosphatase IA-2: potential for mimicry with rotavirus and other environmental agents. Mol Med. 4:(4):1998;231-239.
76. Coulson B.S., Witterick P.D., Tan Y., Hewish M.J., Mountford J.N., Harrison L.C., et al. Growth of rotaviruses in primary pancreatic cells. J Virol. 76:(18):2002;9537-9544.
77. Numazaki K., Goldman H., Wong I., Wainberg M.A. Viral infection of human fetal islets of Langerhans. Replication of human cytomegalovirus in cultured human fetal pancreatic islets. Am J Clin Pathol. 90:(1):1988;52-57.
78. Itoh N., Hanafusa T., Yamagata K., Nakajima H., Tomita K., Tamura S., et al. No detectable cytomegalovirus and Epstein-Barr virus genomes in the pancreas of recent-onset IDDM patients. Diabetologia. 38:(6):1995;667-671.
79. Foy C.A., Quirke P., Williams D.J., Lewis F.A., Grant P.J., Eglin R., et al. A search for candidate viruses in type 1 diabetic pancreas using the polymerase chain reaction. Diabet Med. 11:(6):1994;564-569.
80. Lohr J.M., Oldstone M.B. Detection of cytomegalovirus nucleic acid sequences in pancreas in type 2 diabetes. Lancet. 336:(8716):1990;644-648.
81. Lohr M., Bergstrome B., Maekawa R., Oldstone M.B., Kloppel G. Human cytomegalovirus in the pancreas of patients with type 2 diabetes: is there a relation to clinical features, mRNA and protein expression of insulin, somatostatin, and MHC class II? Virchows Arch A Pathol Anat Histopathol. 421:(5):1992;371-378.
82. Hattersley A.T., Lo Y.M., Read S.J., Eglin R.P., Wainscoat J.S., Clark A. Failure to detect cytomegalovirus DNA in pancreas in type 2 diabetes. Lancet. 339:(8791):1992;459-460.
83. Pak C.Y., Eun H.M., McArthur R.G., Yoon J.W. Association of cytomegalovirus infection with autoimmune type 1 diabetes. Lancet. 2:(8601):1988;1-4.
84. Foy C.A., Quirke P., Lewis F.A., Futers T.S., Bodansky H.J. Detection of common viruses using the polymerase chain reaction to assess levels of viral presence in type 1 (insulin-dependent) diabetic patients. Diabet Med. 12:(11):1995;1002-1008.
85. Nicoletti F., Scalia G., Lunetta M., Condorelli F., Di Mauro M., Barcellini W., et al. Correlation between islet cell antibodies and anti-cytomegalovirus IgM and IgG antibodies in healthy first-degree relatives of type 1 (insulin-dependent) diabetic patients. Clin Immunol Immunopathol. 55:(1):1990;139-147.
86. Banatvala J.E., Bryant J., Schernthaner G., Borkenstein M., Schober E., Brown D., et al. Coxsackie B, mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria, and Australia. Lancet. 1:(8443):1985;1409-1412.
87. Hiltunen M., Hyöty H., Karjalainen J., Leinikki P., Knip M., Lounamaa R., et al. Serological evaluation of the role of cytomegalovirus in the pathogenesis of IDDM: a prospective study. The Childhood Diabetes in Finland Study Group. Diabetologia. 38:(6):1995;705-710.
88. Ivarsson S.A., Lindberg B., Nilsson K.O., Ahlfors K., Svanberg L. The prevalence of type 1 diabetes mellitus at follow-up of Swedish infants congenitally infected with cytomegalovirus. Diabet Med. 10:(6):1993;521-523.
89. Fine P.E., Adelstein A.M., Snowman J., Clarkson J.A., Evans S.M. Long term effects of exposure to viral infections in utero. Br Med J (Clin Res Ed). 290:(6467):1985;509-511.
90. Ward K.P., Galloway W.H., Auchterlonie I.A. Congenital cytomegalovirus infection and diabetes. Lancet. 1:(8114):1979;497.
91. Hiemstra H.S., Schloot N.C., van Veelen P.A., Willemen S.J., Franken K.L., van Rood J.J., et al. Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc Natl Acad Sci USA. 98:(7):2001;3988-3991.
92. Roep B.O., Hiemstra H.S., Schloot N.C., De Vries R.R., Chaudhuri A., Behan P.O., et al. Molecular mimicry in type 1 diabetes: immune cross-reactivity between islet autoantigen and human cytomegalovirus but not Coxsackie virus. Ann N Y Acad Sci. 958:2002;163-165.
93. Pak C.Y., Cha C.Y., Rajotte R.V., McArthur R.G., Yoon J.W. Human pancreatic islet cell specific 38 kilodalton autoantigen identified by cytomegalovirus-induced monoclonal islet cell autoantibody. Diabetologia. 33:(9):1990;569-572.
94. Price P., Baxter A.G., Allcock R.N., Papadimitriou J.M. Factors influencing the effects of murine cytomegalovirus on the pancreas. Eur J Clin Invest. 28:(7):1998;546-553.
95. Strachan D.P. Hay fever, hygiene, and household size. BMJ. 299:(6710):1989;1259-1260.
96. Viskari H.R., Koskela P., Lonnrot M., Luonuansuu S., Reunanen A., Baer M., et al. Can enterovirus infections explain the increasing incidence of type 1 diabetes? Diabetes Care. 23:(3):2000;414-416.
97. Lonnrot M., Knip M., Marciulionyte D., Rahko J., Urbonaite B., Moore W.P., et al. Enterovirus antibodies in relation to islet cell antibodies in two populations with high and low incidence of type 1 diabetes. Diabetes Care. 22:(12):1999;2086-2088.
98. Viskari H., Uibo R., Marciulionyte D., Hermann R., Soltesz G., Ludvigsson J., et al. Enterovirus infections and type I diabetes - international comparison. Diabetologia. 44:(suppl 1):2001;A103.
99. Zinkernagel R.M. Maternal antibodies, childhood infections, and autoimmune diseases. N Engl J Med. 345:(18):2001;1331-1335.
100. Clements G.B., Galbraith D.N., Taylor K.W. Coxsackie B virus infection and onset of childhood diabetes. Lancet. 346:(8969):1995;221-223.
101. Nairn C., Galbraith D.N., Taylor K.W., Clements G.B. Enterovirus variants in the serum of children at the onset of Type 1 diabetes mellitus. Diabet Med. 16:(6):1999;509-513.
102. Andreoletti L., Hober D., Hober-Vandenberghe C., Belaich S., Vantyghem M.C., Lefebvre J., et al. Detection of coxsackie B virus RNA sequences in whole blood samples from adult patients at the onset of type I diabetes mellitus. J Med Virol. 52:(2):1997;121-127.
103. Yin H., Berg A.K., Tuvemo T., Frisk G. Enterovirus RNA is found in peripheral blood mononuclear cells in a majority of type 1 diabetic children at onset. Diabetes. 51:(6):2002;1964-1971.
104. *02 in children with type 1 diabetes associated with enterovirus RNA. J Infect Dis. 187:(10):2003;1562-1570.
105. Lonnrot M., Salminen K., Knip M., Savola K., Kulmala P., Leinikki P., et al. Enterovirus RNA in serum is a risk factor for beta-cell autoimmunity and clinical type 1 diabetes: a prospective study. Childhood Diabetes in Finland (DiMe) Study Group. J Med Virol. 61:(2):2000;214-220.
106. Hyöty H., Hiltunen M., Knip M., Laakkonen M., Vahasalo P., Karjalainen J., et al. A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes. 44:(6):1995;652-657.
107. Hiltunen M., Hyöty H., Knip M., Ilonen J., Reijonen H., Vahasalo P., et al. Islet cell antibody seroconversion in children is temporally associated with enterovirus infections. Childhood Diabetes in Finland (DiMe) Study Group. J Infect Dis. 175:(3):1997;554-560.
108. Lonnrot M., Korpela K., Knip M., Ilonen J., Simell O., Korhonen S., et al. Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort: the Finnish Diabetes Prediction and Prevention Study. Diabetes. 49:(8):2000;1314-1318.
109. Salminen K., Sadeharju K., Lönnrot M., Vähäsalo P., Kupila A., Korhonen S., et al. Enterovirus infections are associated with the induction of beta-cell autoimmunity in a prospective birth cohort study. J Med Virol. 69:(1):2003;91-98.
110. Salminen K., Knip M., Ilonen J., Simell O., Hyöty H. Diagnosis of enterovirus infections by neutralization antibody assay in prediabetic children in a prospective birth cohort study. Annales Universitas Turkuensis. Vol. 541:2003;45-46 University of Turku, Turku (Finland).
111. Martiskainen M, Marciulionyte D, Tauriainen S, Helminen M, Salminen K, Ilonen J, et al. Enterovirus RNA in type 1 diabetic patients. Presented at EuropicAmerica 2002. Falmouth (MA), May 15-19, 2002.
112. Sadeharju K., Hamalainen A.M., Knip M., Lonnrot M., Koskela P., Virtanen S.M., et al. Enterovirus infections as a risk factor for type I diabetes: virus analyses in a dietary intervention trial. Clin Exp Immunol. 132:(2):2003;271- 277.
113. Graves P.M., Rotbart H.A., Nix W.A., Pallansch M.A., Erlich H.A., Norris J.M., et al. Prospective study of enteroviral infections and development of beta-cell autoimmunity. Diabetes autoimmunity study in the young (DAISY). Diabetes Res Clin Pract. 59:(1):2003;51-61.
114. Fuchtenbusch M., Irnstetter A., Jager G., Ziegler A.G. No evidence for an association of coxsackie virus infections during pregnancy and early childhood with development of islet autoantibodies in offspring of mothers or fathers with type 1 diabetes. J Autoimmun. 17:(4):2001;333-340.
115. Tuvemo T., Dahlquist G., Frisk G., Blom L., Friman G., Landin-Olsson M., et al. The Swedish childhood diabetes study III: IgM against coxsackie B viruses in newly diagnosed type 1 (insulin-dependent) diabetic children-no evidence of increased antibody frequency. Diabetologia. 32:(10):1989;745-747.
116. Dahlquist G.G., Boman J.E., Juto P. Enteroviral RNA and IgM antibodies in early pregnancy and risk for childhood-onset IDDM in offspring. Diabetes Care. 22:(2):1999;364-365.
117. Sadeharju K., Lonnrot M., Kimpimaki T., Savola K., Erkkila S., Kalliokoski T., et al. Enterovirus antibody levels during the first two years of life in prediabetic autoantibody-positive children. Diabetologia. 44:(7):2001;818-823.